Search Results 1371-1380 of 18308 for Topical

1. A Phase Ⅲ Study Of Rilvegostomig In Combination With Fluoropyrimidine And Trastuzumab Deruxtecan As The First-line Treatment For HER2-positive Gastric Cancer - Mayo Clinic

   Participation eligibility · Intranasal, inhaled, topical steroids or local steroid injections (eg, intra-articular injection). · Systemic corticosteroids at ...

2. Ixazomib Citrate, Lenalidomide, Dexamethasone, and Zoledronic Acid or Zoledronic Acid Alone After Radiation Therapy in Treating Patients With Solitary Plasmacytoma of Bone - Mayo Clinic

   Please note: Inhaled and topical steroids are permitted. No prior proteasome inhibitor or IMiD use. Prior bisphosphonate use is permitted. For all patients ...

3. A Study Evaluating Pembrolizumab and Epacadostat in Treating Participants With Recurrent, Persistent, or Progressive Ovarian Clear Cell Carcinoma - Mayo Clinic

   Patients with rheumatoid arthritis and other arthropathies, Sjogren's syndrome and psoriasis controlled with topical medication and patients with positive ...

4. A Phase 1 Study Evaluating CPI-0610 in Patients With Previously Treated Multiple Myeloma - Mayo Clinic

   Topical, nasal and inhaled corticosteroids are also allowed; Pregnant or lactating women; Women of child-bearing potential and men with reproductive potential ...

5. A Study Comparing The Effectiveness Of Tiotropium And Olodaterol In Fixed Dose Combination Over Tiotropium Alone In Reducing Moderate To Severe Wosening Of Symptoms In Patients With Severe To Very Severe Chronic Obstructive Pulmonary Disease - Mayo Clinic

   A Study Comparing The Effectiveness Of Tiotropium And Olodaterol In Fixed Dose Combination Over Tiotropium Alone In Reducing Moderate To Severe Wosening Of ...

6. Dose-finding Study Of QGE031 As Add-on Therapy To Evaluate Efficacy And Safety In Patients With CSU - Mayo Clinic

   This is a placebo and active-controlled phase 2b dose-finding study to evaluate efficacy and safety of QGE031 monthly subcutaneous injections as add-on therapy ...

7. A Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of ABBV-181 (Budigalimab) in Adult Participants With HIV-1 - Mayo Clinic

   ... topical or by local injection) therapy within 6 months prior to the first dose of study drug. Current hepatitis B virus or hepatitis C virus infection ...

8. A Study to Evaluate the Safety, Tolerance and Anti-tumor Activity of SAR442257 in Patients with Relapsed/Refractory Multiple Myeloma and Relapsed/Refractory Non-Hodgkin Lymphoma - Mayo Clinic

   Use of topical or inhaled steroids is acceptable. Concomitant oral anticoagulant therapy or low molecular weight heparin (LMWH) (low dose aspirin is allowed) ...

9. A Study to Evaluate Gleolan to Enhance Tumor Visualization in Patients with Newly-diagnosed or Recurrent Meningioma - Mayo Clinic

   quinolones and tetracyclines), and topical preparations containing ALA for 24 hours during the perioperative period (see MOPS for detailed list). 10 ...

10. Publications - Osarenoma U. Olomu, M.D. - Mayo Clinic

    Endoscopic outcomes in patients with AERD treated with topical antibiotics and intranasal corticosteroids. Front Cell Infect Microbiol. 2022; 12:812215 Epub ...